Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q5T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,862
Award facts
- Contract value 100% obligated
- $38,861.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,861.89 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections on January 6, 2026, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s significantly larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare programs globally.
Cosentyx is a TNF inhibitor biologic used primarily in the treatment of rheumatoid arthritis, psoriasis, and ankylosing spondylitis. As a leading pharmaceutical distributor, AmerisourceBergen supplies essential medications and medical commodities across multiple therapeutic domains to support military treatment facilities and federal healthcare systems. This delivery order reflects the company's ongoing role in meeting critical pharmaceutical procurement needs for the Department of Defense's medical supply chain, leveraging its established capacity to efficiently fulfill government contracts for specialty medications required by military personnel and healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F9Q5T?
SPE2DR26F9Q5T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9Q5T worth?
The government has obligated $38,862 on SPE2DR26F9Q5T.
Is contract SPE2DR26F9Q5T an order under another contract?
Yes. SPE2DR26F9Q5T is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q5T competed?
The extent of competition for SPE2DR26F9Q5T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award